COILED THERAPEUTICS PLC
Get an alert when COILED THERAPEUTICS PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£78K
-76.8% lowest in 3 filed years
Net assets
£2.4M
-50.5% lowest in 3 filed years
Employees
5
-16.7% lowest in 3 filed years
Profit before tax
-£3.4M
-180.3% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £200,000 | — | — | — | |
| Operating profit | -£1,929,754 | -£1,116,919 | -£3,348,696 | -199.8% | |
| Profit before tax | -£1,932,233 | -£1,214,569 | -£3,403,961 | -180.3% | |
| Net profit | -£1,744,540 | -£971,803 | -£3,362,074 | -246% | |
| Cash | £537,322 | £337,112 | £78,054 | -76.8% | |
| Total assets less current liabilities | — | £5,571,022 | £2,419,645 | -56.6% | |
| Net assets | £5,499,543 | £4,889,019 | £2,419,645 | -50.5% | |
| Equity | £5,499,543 | £4,889,019 | £2,419,645 | -50.5% | |
| Average employees | 10 | 6 | 5 | -16.7% | |
| Wages | £929,019 | £338,440 | £58,410 | -82.7% | |
| Directors' remuneration | £613,000 | £279,546 | £41,500 | -85.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | -20.0% | -138.4% | |
| Gearing (liabilities / total assets) | 9.7% | 15.0% | 10.2% | |
| Current ratio | 2.26x | 2.02x | 0.43x | |
| Interest cover | — | -11.44x | -60.59x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- COILED THERAPEUTICS PLC 2026-03-26 → present
- ROQUEFORT THERAPEUTICS PLC 2021-12-30 → 2026-03-26
- ROQUEFORT INVESTMENTS PLC 2020-08-17 → 2021-12-30
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- RPG Crouch Chapman LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work performed, we have not identified any material uncertainties relating to events or conditions that may cast significant doubt on the Group's and the parent Company's ability to continue as a going concern for a period of at least twelve months from the date the financial statements are authorised for issue.”
Group structure
- COILED THERAPEUTICS PLC · parent
- Oncogeni Ltd 100%
- Lyramid Pty Ltd 100%
- Tumorkine Pty Limited 100%
- Midkine Investments limited 100%
Significant events
- “On 1 February 2025, the Company entered into a share purchase agreement with Pleiades Pharma Ltd for the sale of its subsidiary, Lyramid Pty Ltd.”
- “On 27 March 2026, the Company completed the AO-252 Transaction which has materially altered its investment proposition.”
- “MK Cell Therapy out-licence to Pleiades Pharma Ltd.”
- “Proposed acquisition of AO-252 licence.”
- “Reverse takeover, fundraise and AIM admission.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ORANA CORPORATE LLP | Corporate Secretary | 2021-12-15 | — | — |
| DUVALL, Jean Marie | Director | 2022-04-05 | Jun 1961 | Swiss |
| STERGIOPOULOS, Sotirios, Dr | Director | 2026-03-27 | Apr 1971 | American |
| VEMPATI, Sridhar | Director | 2026-03-27 | Aug 1977 | American |
| WEST, Stephen Paul | Director | 2020-08-17 | Oct 1972 | British,Australian |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WEST, Stephen Paul | Secretary | 2020-08-17 | 2021-12-15 |
| DISLEY, Darrin Matthew, Dr | Director | 2022-09-16 | 2026-03-27 |
| EVANS, Martin John, Sir | Director | 2022-09-16 | 2025-03-17 |
| FREEMAN, Mark | Director | 2021-10-20 | 2022-09-16 |
| REGINALD, Trevor Ajan | Director | 2022-09-16 | 2025-03-17 |
| ROLLINS, Mark Andrew | Director | 2020-11-02 | 2022-04-04 |
| SINCLAIR, Simon Rupert, Dr | Director | 2022-04-20 | 2026-03-27 |
| STEIN, Michael Lewis, Dr | Director | 2021-03-22 | 2024-05-23 |
| WHIDDON, Glenn Ross | Director | 2020-08-17 | 2021-10-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Stephen Paul West | Individual | Shares 25–50%, Voting 25–50% | 2020-08-17 | Ceased 2021-03-22 |
| Mr Glenn Ross Whiddon | Individual | Shares 25–50%, Voting 25–50% | 2020-08-17 | Ceased 2021-03-22 |
Filing timeline
Last 20 of 64 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-04-25 RESOLUTIONS Resolution
- 2026-04-25 MA Memorandum articles
- 2026-03-26 CERTNM Certificate change of name company
- 2025-12-23 RESOLUTIONS Resolution
- 2025-12-23 RESOLUTIONS Resolution
- 2025-12-23 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-25 | AA | accounts | Accounts with accounts type group | |
| 2026-04-25 | RESOLUTIONS | resolution | Resolution | |
| 2026-04-25 | MA | incorporation | Memorandum articles | |
| 2026-04-09 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-09 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-26 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-12-23 | RESOLUTIONS | resolution | Resolution | |
| 2025-12-23 | RESOLUTIONS | resolution | Resolution | |
| 2025-12-23 | RESOLUTIONS | resolution | Resolution | |
| 2025-12-17 | SH01 | capital | Capital allotment shares | |
| 2025-08-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-25 | SH01 | capital | Capital allotment shares | |
| 2025-05-06 | AA | accounts | Accounts with accounts type group | |
| 2025-03-24 | SH01 | capital | Capital allotment shares | |
| 2025-03-24 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-24 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-31 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 14
- Capital events
- 4
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.